MENU ABOUT US MAKE A DONATION
The Epoch Times
Login
SEARCH
CLOSE
Help Center subscribe newsletter Newsstands Epoch Shop Gift
  • TOP NEWS
  • SPECIAL SERIES
  • SPECIAL COVERAGE
  • LATEST ARTICLES
  • US
    • US News
    • US Features
    • US Politics
    • US Crime News
    • New York
    • San Francisco
    • Los Angeles
  • Opinion
    • Thinking About China
    • Viewpoints
    • Unbridled Evil: The Corrupt Reign of Jiang Zemin in China
    • The Reader’s Turn
  • China News
    • US-China Relations
    • Chinese Regime
    • Business & Economy
    • Chinese Culture
    • China Human Rights
    • Social Issues
    • Organ Harvesting in China
  • World News
    • Africa News
    • Americas
    • Asia & Pacific
    • Canada
    • Europe
    • UK News
    • Australia News
    • International
    • Middle East
  • Business & Markets
    • Companies
    • Economy
    • Markets
    • Real Estate
    • Gold and Commodities
  • ARTS & CULTURE
    • Fine Arts & Craftsmanship
    • Performing Arts
    • Books
    • Traditional Culture
    • Shen Yun Special Coverage
    • Film & TV
  • Science
    • News
    • Space
    • Environment
  • Tech
    • Tech News
    • Tech Products & Reviews
    • Social Media
  • Sports
  • Videos
    • American Thought Leaders
    • China Insider
    • Crossroads
  • Bright
    • Lifestyle
    • Inspired
    • Family & Education
    • Personal Finance
    • American Essence
  • Entertainment
    • Film & TV
    • Entertainment News
  • Health
    • Experts
    • Conditions
    • Life & Wellness
  • Special Topics
    • Battlefields
SEARCH
  • EpochTV
  • US
  • US Politics
  • Opinion
  • World News
  • China
  • Hong Kong
  • Health
  • Bright
  • Arts
  • Falun Gong
  • Premium
  • Markets
  • Games
  • Livestream
  • More

monoclonal antibody

  • FDA Approves Absurd Drug to Delay Diabetes
    FDA Approves Absurd Drug to Delay Diabetes
    A monoclonal antibody injection has been approved for type 1 diabetes. It only costs about $200,000 and comes with a risk of serious side effects. STORY AT-A-GLANCE The U.S. Food ...
    February 13, 2023BY Joseph Mercola
  • FDA Approves Monoclonal Antibody to Treat COVID-19 for First Time
    FDA Approves Monoclonal Antibody to Treat COVID-19 for First Time
    The U.S. Food and Drug Administration (FDA) has, for the first time, approved a monoclonal antibody to treat COVID-19 ...
    December 21, 2022BY Mimi Nguyen Ly
  • Cancer Trial Using Monoclonal Antibody Finds Remission in Every Patient: Report
    Cancer Trial Using Monoclonal Antibody Finds Remission in Every Patient: Report
    A cancer trial has reportedly become the first in the world to completely remove the disease in every ...
    June 6, 2022BY Katabella Roberts
  • FDA Authorizes Emergency Use for Monoclonal Antibody Drug Amid $720 Million Deal
    FDA Authorizes Emergency Use for Monoclonal Antibody Drug Amid $720 Million Deal
    The Food and Drug Administration (FDA) on Friday announced it handed down an emergency use authorization for Eli ...
    February 11, 2022BY Jack Phillips
  • GSK-Vir Monoclonal Antibody Protects Against Omicron Subvariant, Companies Say
    GSK-Vir Monoclonal Antibody Protects Against Omicron Subvariant, Companies Say
    The monoclonal antibody treatment from GlaxoSmithKline (GSK) and Vir BioTechnology protects well against the Omicron subvariant that is ...
    February 10, 2022BY Zachary Stieber
  • FDA Restricts Use of 2 Monoclonal Antibody Treatments
    FDA Restricts Use of 2 Monoclonal Antibody Treatments
    The U.S. Food and Drug Administration (FDA) announced Jan. 24 it is restricting the use of two monoclonal ...
    January 25, 2022BY Mimi Nguyen Ly
  • ‘Some of Them Will Die’: Alabama Hit Hard by Monoclonal Antibody Rationing
    ‘Some of Them Will Die’: Alabama Hit Hard by Monoclonal Antibody Rationing
    The federal government's sudden rationing of monoclonal antibody treatments, which are keeping Americans who get COVID-19 out of ...
    September 18, 2021BY Zachary Stieber
TOP NEWS
  • FAA Issues Emergency Ground Stop for All US Flights for ‘Extraordinary Circumstances’
    NEW By Jill McLaughlin
    FAA Issues Emergency Ground Stop for All US Flights for ‘Extraordinary Circumstances’
  • Supreme Court Takes Up Robinhood Investor Lawsuit
    1hr By Stacy Robinson
    Supreme Court Takes Up Robinhood Investor Lawsuit
  • Supreme Court to Consider Trump’s Asylum Restrictions at Southern Border
    1hr By Jack Phillips
    Supreme Court to Consider Trump’s Asylum Restrictions at Southern Border
  • Cisco Sued in California Over Alleged Link to Human Rights Abuses
    2hr By Eva Fu
    Cisco Sued in California Over Alleged Link to Human Rights Abuses
  • DOJ Says Agencies Should Prioritize English Over Other Languages
    3hr By Jack Phillips
    DOJ Says Agencies Should Prioritize English Over Other Languages
  • Kremlin Says Europe Must Show Readiness to Contribute to Peace Process Before Joining Talks
    3hr By Victoria Friedman
    Kremlin Says Europe Must Show Readiness to Contribute to Peace Process Before Joining Talks
  • New White House Chief of Staff Imposes Restrictions on Meeting With Lobbyists
    5hr By Zachary Stieber
    New White House Chief of Staff Imposes Restrictions on Meeting With Lobbyists
  • Microsoft Outlook Emails Approaching Normal Levels After Outage, Company Says
    5hr By Jack Phillips
    Microsoft Outlook Emails Approaching Normal Levels After Outage, Company Says
  • Trump-Ordered Vaccine Safety Report Delayed Past Deadline
    5hr By Zachary Stieber
    Trump-Ordered Vaccine Safety Report Delayed Past Deadline
  • Global Oil Market Shows First Signs of Rebalancing as Gulf Exports Recover: IEA
    5hr By Evgenia Filimianova
    Global Oil Market Shows First Signs of Rebalancing as Gulf Exports Recover: IEA
The Epoch Times
Copyright © 2000 - 2026 The Epoch Times Association Inc. All Rights Reserved.
Back Top